-

New Brightside Health Research Indicates LLM Empowers Clinicians to Triage Patients with Suicidal Ideation Quickly and Accurately

JMIR Mental Health study shows that GPT-4 predicts mental health crises with similar accuracy, but higher sensitivity and lower specificity, than trained clinicians

SAN FRANCISCO--(BUSINESS WIRE)--Telemental health company Brightside Health today announced results of its peer-reviewed study evaluating the performance of a large language model (LLM) in predicting current and future mental health crisis episodes. The research, published in JMIR Mental Health, showed that OpenAI’s GPT-4 was able to identify and predict a mental health crisis (endorsement of suicidal ideation with plan) with similar accuracy, but higher sensitivity and lower specificity, than trained clinicians.

“In line with our commitment to utilize AI in a safe and controlled manner, this research highlights the potential of large language models for triage and clinical decision support in mental health,” said Dr. Mimi Winsberg, Co-Founder and Chief Medical Officer of Brightside Health. “While clinical oversight remains paramount, technologies such as these can help alleviate provider time shortage and empower providers with risk assessment tools, which is especially crucial for patients at risk of suicide.”

While use cases for AI in healthcare have grown, there has been limited research on using AI for the purpose of mental health crisis prediction. This peer-reviewed research analyzed data from 460 patients on the Brightside Health telehealth platform, including 260 patients who reported suicidal ideation with a plan to act on it, and 200 patients who did not endorse suicidal ideation. Six clinicians and GPT-4 were asked to predict the emergence of suicidal ideation with plan based only on the patient’s chief complaint, in free text, without access to any other patient information. Key results from the study include:

  • Similar accuracy of LLMs compared to clinicians: The data indicated that overall accuracy – i.e. correctly assigning suicidal ideation with plan vs. no suicidal ideation in the 460 examples – across the six clinicians using chief complaint alone ranged from 55.2% to 67% accuracy, with an average of 62.1%. The GPT-4 based model had 61.5% accuracy.
  • Time savings of LLMs: Data showed the average clinician took over three hours to evaluate the 460 samples of text provided, while GPT-4 completed the full evaluation in less than 10 minutes.

This research suggests tools such as GPT-4 hold promise for aiding clinicians in delivering mental health care, including timely care to higher acuity and severity patients. It also adds to Brightside Health’s growing body of research, including a peer-reviewed study published in JMIR Formative Research that demonstrated the reduction of suicidal ideation with treatment on a telehealth platform.

To access the full research, visit https://mental.jmir.org/2024/1/e58129. For more information on Brightside Health, visit www.brightside.com.

About Brightside Health

Brightside Health delivers life-saving mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk, and, with its recent acquisition of Lionrock Recovery, substance use disorder. Powered by proprietary AI, purpose-built technology, and a world-class clinician network, Brightside Health combines precision psychiatry and leading-edge therapeutic techniques to improve patient outcomes across the entire clinical spectrum, affordably and at scale. Brightside Health can be paid for with insurance, including Medicare and Medicaid. Brightside Health is available in all 50 states and D.C. with appointments in 48 hours or less. Learn more at www.brightside.com.

Contacts

Hannah Changi
Brightside Health
press@brightside.com

Brightside Health


Release Versions

Contacts

Hannah Changi
Brightside Health
press@brightside.com

More News From Brightside Health

Brightside Health Earns The Joint Commission’s Gold Seal of Approval®

SAN FRANCISCO--(BUSINESS WIRE)--Today, Brightside Health announced it has been accredited by The Joint Commission and earned their Gold Seal of Approval® for Behavioral Health Care and Human Services. As the leader in standards development promoting quality and safety in health care organizations, The Joint Commission assessed and verified that Brightside Health consistently meets and exceeds industry best practice across its care delivery functions. This prestigious accreditation is in line wi...

Brightside Health Expands to Serve Teens

SAN FRANCISCO--(BUSINESS WIRE)--True to its mission of expanding access to care, Brightside Health now offers mental health services for teens aged 13 to 17, ensuring that younger populations have access to the care they need. With this expansion – and services like virtual intensive outpatient programs for substance use disorder and Crisis Care for elevated suicide risk – Brightside Health further solidifies its position as the industry’s most comprehensive telemental health care platform. In...

Brightside Health Reaches 100% National Coverage for Medicare Part B Beneficiaries

SAN FRANCISCO--(BUSINESS WIRE)--Brightside Health is proud to announce that it is the first telepsychiatry company to serve 100% of Medicare Part B beneficiaries nationwide, expanding access to life-saving mental health care for all who need it. The news comes less than a year after the company shared its initial expansion to Medicare and Medicaid. With this milestone, Brightside Health now serves 130 million covered lives and is the only company providing comprehensive telemental health servic...
Back to Newsroom